Isolated sarcoidosis of accessory spleen in the greater omentum: A case report

Introduction

Sarcoidosis is a multisystemic disease of unknown origin characterized by the formation of non-caseating granulomas. Sarcoidosis occurs worldwide and should be diagnosed upon the clinical presentation for non-caseating granulomas, which are also associated with other infectious diseases, autoimmune disorders and neoplasia. Sarcoidosis is often asymptomatic (1); however, its symptoms may be systemic such as fatigue, fever or weight loss, or organ-specific, such as shortness for breath or cough. Thoracic involvement is the most common presentation, reported in up to 90% of patients (2). However, sarcoidosis can involve almost any other organ, including the skin, eyes and abdominal organs (2). Extra-thoracic disease can occur in association with or in the absence of intra-thoracic disease (3). Involvement of abdominal viscera is seldom, which may resemble certain common infectious or neoplastic conditions. Involvement of the liver and spleen is observed in 40–60% of autopsies (4,5). However, an isolated extrathoracic sarcoidosis accounts for only 10% of patients (6). To the best of our knowledge there have been only 10 cases of splenic sarcoidosis reported in the English literature, data from which are summarized in Table I. Accessory spleens (AS) might be formed during embryonic development as separated or ectopic splenic tissue. They are usually near the splenic hilum, but may be located in the greater omentum (7). There are no previous reports of accessory splenic sarcoidosis. Herein, we report a case of isolated sarcoidosis of an accessory spleen in the greater omentum, which was identified postoperatively in a 44-year-old female.

Table I. Reports of splenic sarcoidosis.

Table I.

Reports of splenic sarcoidosis.

Case	Author, year	Gender	Age (years)	Symptoms	Lesion number	Nodular size (mm)	Laboratory tests	Abdominal CT	MRI	PET-CT	Surgical treatment	Refs.
1	Zia et al, 2005	F	47	Nausea, epigastric pain	Multiple	Unknown	Elevated bilirubin and AST	Confirmed multiple splenic nodules	–	Five focal areas of increased uptake in the splenic parenchyma	LS	(12)
2	Chen et al, 2009	M	50	–	Multiple	Unknown	Thrombopenia	Primary lymphoma	–	–	LS	(17)
3	Givoinale et al, 2009	F	32	Epigastric pain	Multiple	15	Mild anemia, elevated ACE	–	Splenomegaly with multiple splenic lesions	–	LS	(16)
4	Joglekar et al, 2009	F	46	Back and leg pain	Multiple	Unknown	Raised serum calcium, urea, creatinine and ESR	Borderline enlarged spleen, multiple low density coalescent nodular lesions	Posterocentral and right posterolateral disc protrusion at L5/S1 with compression of thecal sac	–	OS	(11)
5	Ogiwara et al, 210	F	74	Cold sweats, palpitation	Single	60×57×60	Low plasma glucose, low serum potassium, serum immunoreactive insulin and C-peptide level undetectable	Splenic mass with central contrast enhancement	Normal pituitary gland and hypothalamic region	Normal pituitary gland and hypothalamic region	OS	(18)
6	Cuilliere-Dartigues et al, 2010	M	18	Night sweats, severe neutropenia	Multiple	10–30	ACE normal	Mild splenomegaly with diffuse nodular lesions	–	Intense splenic uptake	LS	(19)
7	Palade et al, 2012	F	66	Splenomegaly, hypersplenism, secondary anemia	Unknown	Unknown	Mild hypochromia	–	–	–	OS	(13)
8	Bauones et al, 2013	F	37	Chronic abdominal discomfort	Multiple	14–60	Normal	Multiple hypodense splenic nodules with inhomogenous enhancement	Multiple splenic nodules with heterogenous enhancement	–	LS	(10)
9	Souto et al, 2014	F	29	–	Multiple	10, mostly	Normal	Multiple lesions in the spleen with homogeneous enhancement	Multiple splenic lesions with homogeneous enhancement, low signal on T1 and high signal on T2	No fluorodeoxyglucose uptake in the spleen	LS	(9)
10	Dennis et al, 2014	M	65	Headache, weakness, gait instability, impaired cognition, weight loss	Unknown	Unknown	Hypercalcium, hypoparathyroid, decreased 25- hydroxyvitamin D hormone	Mild splenomegaly without focal lesions	–	Intense uptake in the spleen, malignancy?	HALS	(20)

[i] CT, computed tomography; MRI, magnetic resonance imaging; PET-CT, positron emission tomography-computed tomography; ACE, angiotensin converting enzyme; ESR, erythrocyte sedimentation rate; LS, laparoscopic splenectomy; OS, open splenectomy; HALS, hand assisted laparoscopic splenectomy.

Case report

A 44-year-old female presented to the Department of General Surgery of Lishui Central Hospital (Lishui, China) complaining of pain beneath the xiphoid process for two years. The patient denied any personal history of surgery or family history of cancer. Physical examination presented with normal results. The liver and spleen presented normally. Chest X-ray results were normal (Fig. 1). Gastric endoscopy showed an ulcer in the antrum measuring 1.5×1.5 cm, which was confirmed to be a signet-ring cell carcinoma by biopsy. Computed tomography (CT) of the abdomen revealed mild thickening of the posterior antrum, and a mass measuring 5×4 cm in the inferior pole of the left kidney. No abnormal foci could be found in the greater omentum or other organs. There was no associated splenomegaly (Figs. 2 and 3). Mycobacterial, fungal, bacterial and parasitic infections were all excluded. After four days of preoperative preparation, including liver function, renal function and blood coagulation function blood tests and the exclusion of surgical contraindications, the patient underwent surgical exploration. Intraoperatively, a solid ulcer was detected in the antrum measuring 1×1 cm, and a solid mass measuring 5×4 cm was identified in the inferior pole of left kidney. The accessory spleen in the greater omentum was not explored. There were no evident masses in the liver and spleen. In the abdominal cavity, pelvic cavity, mesenteric and para-aorta, no enlarged lymph nodes were detected. Radical distal gastrectomy and left radical nephrectomy, with a midline incision from the xiphoid to umbilicus, were performed.

Figure 1. Chest X-ray showing no foci in the lungs.

Figure 2. Contrast computed tomography showing mild thickening of the posterior antrum and normal spleen.

Figure 3. Contrast computed tomography showing a mass measuring 5×4 cm in the inferior pole of left kidney.

Radical distal gastrectomy was completed as follows: i) The greater omentum was separated from the transverse colon, followed by resection of the superior leaf of the transverse mesocolon; ii) the gastroepiploic vein and artery were separately ligated, and the anterior pancreatoduodenal and infrapyloric nodes, retroduodenopancreatic lymph nodes and nodes of inferior portion of the hepatododenal ligament were resected; iii) the right gastric artery was ligated, and the duodenum was transected and closed ~3 cm from the pylorus; iv) the lymph nodes and the tissue surrounding the celiac trunk were resected, and the left gastric vein was ligated at its origin followed by the left artery; v) dissection continued up the lesser curvature of the stomach, where the right paracardial zone was dissected and two short gastric veins were ligated; vi) the upper portion of the stomach was transected using a Proximate linear cutter (Ethicon Endo-Surgery, LLC, Guaynabo, Puerto Rico), and the right broken line of the stomach was 3 cm below the cardia, whereas the left was above the origin of the second resected gastric short vein; and vii) Hofmeister's gastrojejunal anastomosis (Billroth II) was performed (8). Left radical nephrectomy was performed as follows: i) Left posterior peritoneum and perirenal fascia were incised; ii) after the left renal pedicle was divided, the left renal artery and vein were separately ligated; iii) the left renal, perirenal fat and fascia were divided; and iv) after the left ureter was resected below the iliac vessels, the specimen was removed.

In addition to signet-ring cell carcinoma in the antrum and the left renal clear cell cancer, postoperative pathology demonstrated a red lesion measuring 0.5×0.5 cm in the greater omentum, which was similar to the spleen in the normal splenic cavity and was thus regarded as an accessory spleen. Histological examination of the lesion in the greater omentum revealed small and dense epithelioid non-caseating granulomas, with clear margins surrounded by a small quantity of lymphocytic infiltrates (Fig. 4). Fungi were excluded using periodic acid-Schiff and hexamine silver staining. Acid-fast bacilli were excluded by acid-fast staining. Acid-Schiff and hexamine silver staining were performed using 0.5% potassium permanganate solution, 8% chromic acid solution, 5% silver nitrate solution, 3% hexamethylene tetramine solution, 5% sodium tetraborate solution, 0.1% gold chloride solution and 5% sodium thiosulfate (Sinopharm Chemical Reagent Co., Ltd., Shanghai, China). Phenol fuchsine fluid and Mayer's hemalum solution (Fuzhou Maixin Biotech. Co., Ltd., Fuzhou, China) were used for acid-fast bacilli staining.

Figure 4. Small and dense epithelioid non-caseating granulomas with clear margin surrounded by a small quantity of lymphocytic infiltration (stain, hematoxylin and eosin; magnification, ×100).

In consideration of the aforementioned tests, sarcoidosis of accessory spleen in the greater omentum was confirmed. The patient recovered uneventfully and was discharged on day 8 postoperation. The patient remained alive after two-year follow-up without sarcoidosis and malignant tumor recurrence.

Discussion

In the present study a rare case of sarcoidosis of accessory spleen in the greater omentum was reported. Sarcoidosis is observed worldwide, the incidence rate of the disease, organs involved, manifestations and prognosis vary widely with geography and ethnicity. A diagnosis of sarcoidosis is based on clinical and radiological results (6), in addition to the histology of epithelioid granulomas (9). However, granulomas are not a specific finding of sarcoidosis, and other diseases such as infections caused by bacteria or fungi and environmental agents must be excluded. The lungs are involved in 90% of patients with sarcoidosis; however, almost any other organ may be involved, yet the digestive tract is rarely involved (2,5,10,11). Gastrointestinal symptoms might exist and are variable depending on the location of disease (8,12,13). The frequency of splenomegaly in sarcoidosis may range between 1 and 40% (14,15). Correlation between pulmonary abnormalities and hepatosplenic involvement has not yet been established (16). Autopsy studies have revealed splenic involvement in 38–77% of patients with sarcoidosis (1). Isolated splenic sarcoidosis is rare (1). Sarcoidosis of the spleen without clinical or radiographic pulmonary disease is exceedingly rare, with only sporadic cases reported. There have been only 10 cases of isolated splenic sarcoidosis, and no reports of sarcoidosis in the accessory spleen (Table I). Due to the popularity and small size of the accessory spleen, the operator ignored it intraoperatively. Splenic sarcoidosis exhibits a female preference (7:3 female to male ratio), with a median age of 46.5 years. Patients may be asymptomatic (9,17), or exhibit abdominal pain (12,16). Other atypical symptoms include sweats (18,19), weakness and weight loss (20). The incidence of splenomegaly associated with sarcoidosis is variable, but may be has high as 40% (21). Massive splenomegaly is quite rare; Fordice et al (22) reviewed 6,074 cases of sarcoidosis, 628 patients had quantified splenomegaly and 20 (3%) had massive splenomegaly. Splenic infarction due to sarcoidosis was has been reported (23). Symptoms related to hypersplenism with anemia, thrombocytopenia and leucopenia have been reported (6). However, massive splenomegaly in sarcoidosis may not result in a pathophysiological effect (17). As the present case exhibited two malignant tumors. Whether the incidence of splenic sarcoidosis is related to the tumors requires confirmation.

Routine laboratory tests are not usually helpful in the diagnosis of sarcoidosis as these tests are nonspecific. However, peripheral lymphopenia with CD4 depletion, elevated levels of serum-angiotensin converting enzyme (S-ACE), lysozyme, β-2 microglobulin, hypercalcemia and hypercalciuria can be helpful to the diagnosis (24). ACE (25) is elevated in 60% of cases, hypercalcemia or hypercalciuria occur in about 10–40% of patients (6). Lymphocytic alveolitis with a high CD4/CD8 ratio in bronchoalveolar lavage (BAL) fluid is highly suggestive of the disease (24). Warshauer et al (1) observed a linear association between serum ACE level and spleen size as well as between ACE level and the presence of hepatosplenic nodules; however, no correlation between the degree of chest abnormality and the involvement of liver and spleen was identified (2). In these cases, the diagnosis of sarcoidosis could be difficult as sarcoidosis is often not considered due to the nonspecific nature of laboratory tests.

The imaging features of splenic sarcoidosis are variable. Radiographic results of isolated splenic lesions are nonspecific and own many differential diagnoses including lymphoma, metastatic disease, hematomas, abscesses, hamartomas, and angiosarcomas (26). Certainly, a histopathologic diagnosis for definitive diagnosis is needed. The spleen is often enlarged; and hypodense splenic nodules can be seen in approximately 15% of patients (1). Lesions are often multiple and diffused distributed; however, they may be undetectable (20). The majority of nodules are between 0.1 and 3.0 cm, with a mean of ~1.0 cm. Notably, Bauones et al (10) observed capsular retraction on ultrasound and magnetic resonance images (MRI), and confirmed at gross examination. This unreported imaging feature in splenic sarcoidosis may be associated with the presence of significant collagen fibrosis that surrounded the granulomas. Notably, in the spleen capsular retraction is rarely reported, in relation to splenic infarction or neoplastic disease (27). In particular, there was no thoracic and lymphatic system involvement to suggest sarcoidosis in this patient. Kessler et al (28) concluded that focal lesions in spleen in sarcoidosis patients can occasionally be detected by ultrasound; however, diffuse increased homogeneous or heterogeneous echogenicity is more common. Pérez-Grueso et al (5) initially adopted contrast enhanced ultrasound (CEUS) to diagnose splenic sarcoidosis. Grzelak et al (29) implemented CEUS to diagnose two cases of hepatosplenic sarcoidosis, and concluded that CEUS has the potential to become a reliable tool; replacing more expensive and less available imaging methods, such as CT and MRI. However, certain cases exhibited a tumor-like pattern under CEUS; consisting of slight but diffuse enhancement of the lesions in the arterial phase followed by progressive hypoenhancement in the parenchymal phase (30). Tana et al (31) speculated that this may be related to different vascularization of the lesions and suggested the need for further studies before making definite conclusions. In one report, lesions visible on contrast-enhanced CT were not observed under sonography, suggesting that the acoustic impedance of the granulomas was similar to that of normal splenic tissue (11,32). Dynamic gadolinium-enhanced MRI is useful in characterizing splenic lesions and narrowing the differential diagnosis. Classically sarcoidosis-related splenic lesions are T1 and T2 hypointense and relatively hypoenhancing (33). Positron emission tomography-CT is a useful imaging method for the evaluation of disease activity and the identification of areas that are undetectable by ultrasound, CT and MRI, as well as in monitoring response to treatment in patients with sarcoidosis. Among the reviewed cases, which employed PET-CT, intense fluorodeoxyglucose uptake in the spleen was detected in 75% of patients (9,12,19,20). Kataoka et al (34) suggested multiple imaging modalities, including dynamic CT and MRI for detecting splenic lesions of sarcoidosis. Due to the risk of bleeding, tract seeding and variable results, a percutaneous biopsy via ultrasound or CT was not suggested. Without lung or other systemic involvement, the symptoms of splenic sarcoidosis may resemble more serious neoplastic or infectious disease (6), and in this context only splenectomy allows the establishment of a diagnosis. Following diagnosis, patients require continual follow-up for systemic manifestations and associated complications of sarcoidosis. None of the presently reviewed 10 cases were diagnosed preoperatively. The present case was accidently identified postoperative pathology.

Splenectomy is considered as a treatment option for hypersplenism, prophylaxis for splenic rupture and neoplastic exclusion (16). Splenectomy might not alter the course of disease and is merely an adjunct to medical therapy in order to resolve complications of sarcoidosis (35). With the improvements in the technologies, laparoscopic splenectomy has gradually become the gold standard for surgical removal of the spleen, and there have been reported laparoscopic splenectomies performed for sarcoidosis (9,12). Laparoscopic splenectomy is a minimally invasive procedure that provides superior aesthetic results, decreased blood loss and decreased postoperative complications and faster recovery, which allows the earlier initiation of chemotherapy. If a splenectomy is to be performed, comprehensive exploration should be conducted to exclude the accessory spleen, which may also suffer from sarcoidosis. In the presently reviewed cases, hypercalcemia and hypersplenism disappeared after splenectomy (11,13). As isolated splenic disease may be only a precursor to future systemic disease, and thus patients must be followed over their lifetimes. Asymptomatic patients do not require the immunosuppressive drugs; however, if symptoms do occur, steroids or even methotrexate and azathioprine can be used. As many as 66% of patients spontaneously remit (6). The lack of response or the appearance of complications may require splenectomy (12). In the majority of cases the recommended therapy is using glucocorticoid, which should be resumed in the instance of a relapse.

In summary, one rare case of isolated sarcoidosis of accessory spleen in the greater omentum is reported. Symptoms of splenic sarcoidosis are atypical, requiring multiple imaging modalities for detection Splenectomy was indicated for symptoms, hypersplenism, prophylaxis for splenic rupture and neoplastic exclusion. Intraoperatively, comprehensive exploration should be conducted to exclude the accessory spleen, which may also suffer from sarcoidosis.

References